S&P 500
(0.00%) 5 420.79 points
Dow Jones
(-0.36%) 38 574 points
Nasdaq
(0.10%) 17 625 points
Oil
(0.27%) $78.71
Gas
(-2.89%) $2.96
Gold
(-1.53%) $2 318.80
Silver
(-4.19%) $29.00
Platinum
(-1.65%) $955.00
USD/EUR
(0.73%) $0.931
USD/NOK
(0.79%) $10.65
USD/GBP
(0.39%) $0.784
USD/RUB
(-0.69%) $88.37

Realtime updates for Dimerix Ltd [DXB.AX]

Exchange: ASX Industry: Pharmaceuticals, Biotechnology & Life Sciences
Last Updated13 Jun 2024 @ 02:10

-4.13% $ 0.580

Live Chart Being Loaded With Signals

Commentary (13 Jun 2024 @ 02:10):
Profile picture for Dimerix Ltd

Dimerix Limited, a biopharmaceutical company, develops and commercializes pharmaceutical products for unmet medical needs. It develops DMX-200 that is in two Phase 3 clinical trials for COVID respiratory complications; DMX-200, a Phase 3 clinical trial for focal segmental glomerulosclerosis disease; DMX-200 for diabetic kidney disease; and DMX-700 for chronic obstructive pulmonary disease...

Stats
Today's Volume 4.31M
Average Volume 4.92M
Market Cap 295.12M
EPS $-0.0164 ( Q2 | 2023-12-31 )
Next earnings date ( $0 ) 2024-07-25
Last Dividend $1.237 ( 1999-09-24 )
Next Dividend $0 ( N/A )
P/E -19.33
(Sector) 0
(Industry) 0
ATR14 $0.00300 (0.51%)
ACW.AX -9.09%
ADO.AX 0.00%
AGH.AX 4.55%
ANP.AX -4.92%
ATH.AX 25.00%
AVE.AX 33.33%
BIT.AX -2.17%
BNO.AX -10.00%
BOT.AX 8.77%
CAN.AX -6.25%
CPH.AX 0.00%
CSL.AX 2.03%
CTE.AX 4.76%
CUV.AX 2.01%
CYP.AX 1.52%
DXB.AX -4.13%
ECS.AX -5.88%
EOF.AX 5.88%
GSS.AX -2.78%
IDT.AX -8.00%
IMC.AX 1.14%
IMM.AX 2.50%
IMU.AX 1.75%
IXC.AX 0.00%
KZA.AX 9.59%
LCT.AX 7.14%
LGP.AX 0.00%
MSB.AX 1.87%
MVP.AX -2.50%
MXC.AX 2.44%
NEU.AX 2.60%
NOX.AX -4.29%
NSB.AX -15.00%
OCC.AX 1.35%
OPT.AX 0.00%
OSL.AX 0.00%
PAA.AX 0.00%
PAB.AX 0.00%
PAR.AX -4.17%
PBP.AX 0.00%
PIQ.AX -3.76%
PTX.AX -4.55%
PXS.AX 3.70%
PYC.AX 5.00%
RAC.AX -1.32%
RCE.AX -0.90%
SPL.AX -1.00%
TLX.AX -1.20%
VBS.AX 4.76%

Volume Correlation

Long: 0.01 (neutral)
Short: 0.80 (strong)
Signal:(58.263) Same movement expected

Dimerix Ltd Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Dimerix Ltd Correlation - Currency/Commodity

The country flag 0.54
( weak )
The country flag 0.64
( weak )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag 0.57
( weak )

Dimerix Ltd Financials

Annual 2023
Revenue: $8.98M
Gross Profit: $8.93M (99.38 %)
EPS: $-0.0424
FY 2023
Revenue: $8.98M
Gross Profit: $8.93M (99.38 %)
EPS: $-0.0424
FY 2023
Revenue: $0
Gross Profit: $0 (0.00 %)
EPS: $0
FY 2022
Revenue: $6.46M
Gross Profit: $6.41M (99.22 %)
EPS: $-0.0350

Financial Reports:

No articles found.

Dimerix Ltd Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)

Dimerix Ltd Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 4.82 - low (60.09%) | Divividend Growth Potential Score: 0.231 - No dividend growth expected in the near future
Information
First Dividend $6.93 1998-09-18
Last Dividend $1.237 1999-09-24
Next Dividend $0 N/A
Payout Date 1999-05-21
Next Payout Date N/A
# dividends 2 --
Total Paid Out $8.16 --
Avg. Dividend % Per Year 0.00% --
Score 1.28 --
Div. Sustainability Score 4.82
Div.Growth Potential Score 0.231
Div. Directional Score 2.53 --
Next Divdend (Est)
(2024-06-24)
$0 Estimate 0.00 %
Dividend Stability
0.00 Very Bad
Dividend Score
1.28
Pay Frequency
Annually
Yearly Payout
Year Amount Yield

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for ASX

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
FAR.AX No Dividend Player 2023-08-23 Sporadic 0 0.00%
SEQ.AX No Dividend Player 2023-09-12 Annually 0 0.00%
BTI.AX Ex Dividend Junior 2023-08-21 Sporadic 0 0.00%
NHF.AX Ex Dividend Knight 2023-09-04 Semi-Annually 0 0.00%
HZN.AX Ex Dividend Knight 2023-10-17 Annually 0 0.00%
TPG.AX Ex Dividend Knight 2023-09-12 Semi-Annually 0 0.00%
CRN.AX Ex Dividend Junior 2023-08-28 Annually 0 0.00%
PPE.AX Ex Dividend Knight 2023-08-31 Semi-Annually 0 0.00%
AMH.AX Ex Dividend Knight 2023-08-04 Annually 0 0.00%
MAD.AX Ex Dividend Knight 2023-09-19 Semi-Annually 0 0.00%

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM-1.1921.500-10.00-10.00[0 - 0.5]
returnOnAssetsTTM-0.7201.200-10.00-10.00[0 - 0.3]
returnOnEquityTTM-2.831.500-10.00-10.00[0.1 - 1]
payoutRatioTTM0-1.00000[0 - 1]
currentRatioTTM4.840.80010.008.00[1 - 3]
quickRatioTTM4.840.80010.008.00[0.8 - 2.5]
cashRatioTTM4.761.50010.0010.00[0.2 - 2]
debtRatioTTM0.0947-1.5008.42-10.00[0 - 0.6]
interestCoverageTTM01.000-1.111-1.111[3 - 30]
operatingCashFlowPerShareTTM0.001742.0010.0010.00[0 - 30]
freeCashFlowPerShareTTM0.001722.0010.0010.00[0 - 20]
debtEquityRatioTTM0.832-1.5006.67-10.00[0 - 2.5]
grossProfitMarginTTM1.0001.00010.0010.00[0.2 - 0.8]
operatingProfitMarginTTM-2.181.000-10.00-10.00[0.1 - 0.6]
cashFlowToDebtRatioTTM0.4941.0008.378.37[0.2 - 2]
assetTurnoverTTM0.6040.8009.317.44[0.5 - 2]
Total Score4.82

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM-22.591.000-2.380[1 - 100]
returnOnEquityTTM-2.832.50-10.00-10.00[0.1 - 1.5]
freeCashFlowPerShareTTM0.001722.0010.0010.00[0 - 30]
dividendYielPercentageTTM01.50000[0 - 0.4]
operatingCashFlowPerShareTTM0.001742.0010.0010.00[0 - 30]
payoutRatioTTM01.50000[0 - 1]
pegRatioTTM0.02591.500-3.160[0.5 - 2]
operatingCashFlowSalesRatioTTM0.07741.000-0.5660[0.1 - 0.5]
Total Score0.231

Dimerix Ltd Options Data

Calls

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Puts

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Dimerix Ltd

Dimerix Limited, a biopharmaceutical company, develops and commercializes pharmaceutical products for unmet medical needs. It develops DMX-200 that is in two Phase 3 clinical trials for COVID respiratory complications; DMX-200, a Phase 3 clinical trial for focal segmental glomerulosclerosis disease; DMX-200 for diabetic kidney disease; and DMX-700 for chronic obstructive pulmonary disease. The company is headquartered in Fitzroy, Australia.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators

Total Execution Time: 1.5165951251984 seconds
Number of API calls: 3
Number of DB calls: 9